1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SETD2 CTRPv2 pan-cancer AAC 0.17 8e-06
mRNA BCL2L1 CTRPv2 pan-cancer AAC -0.16 8e-06
mRNA PELP1 CTRPv2 pan-cancer AAC 0.15 8e-06
mRNA NUDT3 CTRPv2 pan-cancer AAC 0.17 8e-06
mRNA PRR3 CTRPv2 pan-cancer AAC 0.17 8e-06
mRNA NME9 CTRPv2 pan-cancer AAC 0.14 8e-06
mRNA KDM3B CTRPv2 pan-cancer AAC 0.15 8e-06
mRNA R3HDM1 CTRPv2 pan-cancer AAC 0.16 8e-06
mRNA RBM25 CTRPv2 pan-cancer AAC 0.15 8e-06
mRNA BCOR CTRPv2 pan-cancer AAC 0.16 8e-06
Download CSV